April 15, 2021

Robert Shepler

Bob has served on Akoya Bioscience’s board since the company’s inception in 2015.  Bob was a founder and served as a Managing Director of Telegraph Hill […]
April 15, 2021

Seth Benson

Seth joined Akoya Biosciences in December of 2018 as Vice President of Business Operations. He has over 15 years of experience in finance, strategy, and operations […]
April 15, 2021

Gavin Gordon, PhD

Gavin joined Akoya in July of 2020 to lead business and market development activities with the goal of establishing Akoya platforms in clinical markets. Prior to […]
April 15, 2021

Sundiep Phanse, PhD

Sundiep joined Akoya in April 2019 and brings a wealth of expertise from her prior leadership roles at companies such as Lam Research, Natera, and Thermo […]
April 15, 2021

Paul Grass

Paul joined Akoya in January of 2018 as the head of sales. He has over 20 years of experience in customer support, marketing, and sales leadership […]
April 15, 2021

Cliff Hoyt

Prior to joining Akoya Biosciences, Cliff was Director of Applications and Services for PerkinElmer’s Quantitative Pathology Business Unit. Cliff was co-founder and CTO of CRI, Inc., […]
April 15, 2021

Julia Kennedy-Darling, PhD

Dr. Julia Kennedy-Darling joined Akoya in March of 2017 to lead development efforts for the CODEX technology. Prior to joining Akoya, Julia was a co-inventor of […]
April 15, 2021

Peter Miller

Prior to joining Akoya Biosciences, Peter was Director of R&D for PerkinElmer’s Quantitative Pathology Business Unit. Peter was a co-founder of CRI, Inc., where he was […]
April 15, 2021

Frederic Pla, PhD

Frederic joined Akoya Biosciences in April 2021 to serve as the Chief Operating Officer. He brings over 25 years of experience in launching and managing global […]
April 15, 2021

Niro Ramachandran, PhD

Niro joined Akoya in August 2020 to serve as the Chief Business Officer responsible for developing a robust roadmap and commercialization strategy for Akoya’s platforms. Niro […]